TAURX THERAPEUTICS LTD.
- Country
- 🇸🇬Singapore
- Ownership
- Private
- Established
- 2002-01-01
- Employees
- 501
- Market Cap
- -
- Website
- http://taurx.com
TRx0237 for the Treatment of Early and Mild-Moderate Alzheimer's Disease
- Conditions
- Alzheimer Disease
- First Posted Date
- 2018-05-29
- Last Posted Date
- 2024-09-27
- Lead Sponsor
- TauRx Therapeutics Ltd
- Registration Number
- NCT03539380
Safety and Efficacy of TRx0237 in Subjects With Alzheimer's Disease Followed by Open-Label Treatment
- Conditions
- Alzheimer Disease
- Interventions
- Drug: PlaceboDrug: TRx0237 16 mg/dayDrug: TRx0237 8 mg/day
- First Posted Date
- 2018-02-26
- Last Posted Date
- 2023-05-24
- Lead Sponsor
- TauRx Therapeutics Ltd
- Target Recruit Count
- 598
- Registration Number
- NCT03446001
- Locations
- 🇺🇸
Visionary Investigators Network, Miami, Florida, United States
🇺🇸Finlay Medical Research, Miami, Florida, United States
🇺🇸Health Care Family Rehab and Research, Miami, Florida, United States
Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
- Conditions
- Behavioral Variant Frontotemporal DementiaAlzheimer's Disease
- Interventions
- First Posted Date
- 2014-09-19
- Last Posted Date
- 2023-05-24
- Lead Sponsor
- TauRx Therapeutics Ltd
- Target Recruit Count
- 913
- Registration Number
- NCT02245568
- Locations
- 🇺🇸
Feldman, Robert MD, Laguna Hills, California, United States
🇺🇸The Shankle Clinic, Newport Beach, California, United States
🇺🇸Pacific Research Network, San Diego, California, United States
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
- Conditions
- Alzheimer's Disease
- Interventions
- Drug: TRx0237 200 mg/dayDrug: Placebo
- First Posted Date
- 2012-09-21
- Last Posted Date
- 2018-03-14
- Lead Sponsor
- TauRx Therapeutics Ltd
- Target Recruit Count
- 800
- Registration Number
- NCT01689233
- Locations
- 🇦🇺
Discipline of Psychiatry, University of Queensland, Herston, Queensland, Australia
🇺🇸Brain Matters Research, Delray Beach, Florida, United States
🇺🇸The Roskamp Institute, Inc., Sarasota, Florida, United States
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
- Conditions
- Alzheimer's Disease
- Interventions
- Drug: TRx0237 250 mg/dayDrug: TRx0237 150 mg/dayDrug: Placebo
- First Posted Date
- 2012-09-21
- Last Posted Date
- 2018-03-14
- Lead Sponsor
- TauRx Therapeutics Ltd
- Target Recruit Count
- 891
- Registration Number
- NCT01689246
- Locations
- 🇺🇸
Brain Matters Research, Delray Beach, Florida, United States
🇵🇱NZOZ Wielospecjalistyczna Poradnia Lekarska SYNAPSIS, Katowice, Poland
🇵🇱Gabinet Neurologiczny, Indywidualna Specjalistyczna Praktyka Lekarska, Mosina, Poland
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
- Conditions
- Behavioral Variant Frontotemporal Dementia (bvFTD)
- Interventions
- Drug: Placebo
- First Posted Date
- 2012-06-22
- Last Posted Date
- 2018-03-14
- Lead Sponsor
- TauRx Therapeutics Ltd
- Target Recruit Count
- 220
- Registration Number
- NCT01626378
- Locations
- 🇺🇸
University Hospitals Case Medical Center, Neurology Clinical Trials Unit, Cleveland, Ohio, United States
🇨🇦Toronto Memory Program, Toronto, Ontario, Canada
🇺🇸UNC Department of Neurology, Physicians Office Building, Chapel Hill, North Carolina, United States
Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease
- First Posted Date
- 2012-06-22
- Last Posted Date
- 2014-07-11
- Lead Sponsor
- TauRx Therapeutics Ltd
- Target Recruit Count
- 9
- Registration Number
- NCT01626391
Multiple Dose Study of TRx0037
- First Posted Date
- 2010-12-03
- Last Posted Date
- 2010-12-17
- Lead Sponsor
- TauRx Therapeutics Ltd
- Target Recruit Count
- 31
- Registration Number
- NCT01253499
Comparative Bioavailability in Healthy Elderly Volunteers
- First Posted Date
- 2010-12-03
- Last Posted Date
- 2010-12-03
- Lead Sponsor
- TauRx Therapeutics Ltd
- Target Recruit Count
- 24
- Registration Number
- NCT01253122
Open Label Study of TRx0014 in Alzheimer's Disease
- First Posted Date
- 2008-05-28
- Last Posted Date
- 2018-04-27
- Lead Sponsor
- TauRx Therapeutics Ltd
- Target Recruit Count
- 111
- Registration Number
- NCT00684944